Mjf. Starmanskool et al., AN UNWANTED SIDE-EFFECT OF HYDROXYUREA IN A PATIENT WITH IDIOPATHIC MYELOFIBROSIS, Annals of hematology, 70(5), 1995, pp. 279-280
A patient with idiopathic myelofibrosis is reported who developed a dr
ug fever after treatment with hydroxyurea, a generally effective and w
ell-tolerated drug in chronic myeloproliferative syndromes. Typically,
this form of fever develops after a few weeks of exposure to the drug
and disappears with discontinuation of the drug. Possible interaction
s with prostaglandin or leukotriene metabolism may play a role.